OncologyTube Professional - Patients Click Here
341,520 video views
Loading........
Description: Michael A.S. Jewett DEPARTMENT OF SURGICAL ONCOLOGY PRINCESS MARGARET CANCER CENTRE DIVISION OF UROLOGY THE UNIVERSITY OF TORONTO discusses Heterogeneity of Renal Cell Carcino...
01:02
Kathleen Mahoney, M.D. Instructor, Medicine, Harvard Medical School Discusses Protein Biomarkers, PD-L1, & Multifactorial. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 252 views
01:19
Kathleen Mahoney, M.D. Instructor, Medicine, Harvard Medical School Discusses Is The Secreted Variant Of PD-L1 A Systemic Immunosuppressa​nt. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 218 views
01:36
Kathleen Mahoney, M.D. Instructor, Medicine, Harvard Medical School Discusses Data Regarding A Splice Variant Of PD-L1. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 181 views
01:06
John Leppert, M.D., M.S. Associate Professor - Med Center Line, Urology At Stanford University Discusses Which Patient For Which Treatment. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 208 views
00:58
John Leppert, M.D., M.S. Associate Professor - Med Center Line, Urology At Stanford University Discusses Over-Diagnosis & Over-Treatment Of Kidney Cancer. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 231 views
00:47
John Leppert, M.D., M.S. Associate Professor - Med Center Line, Urology At Stanford University Discusses Increasing Awareness In Kidney Cancer. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 82 views
00:51
John Leppert, M.D., M.S. Associate Professor - Med Center Line, Urology At Stanford University Discusses How To Better Treat Kidney Cancer. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 30 views
04:11
Abhishek Tripathi, M.D. Assistant Professor Of Medicine In The Section Of Hematology/Onco​logy At Oklahoma Stephenson Cancer Center Discusses Adenosine Pathway Inhibitors In Kidney Cancer. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 27 views
00:42
Steven Raman, M.D. Director of Prostate MR Imaging and Interventions and UCLA Prostate MR Imaging Research Group Discusses, MRPET & The Future Of Imaging. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 26 views
01:53
Tian Zhang, M.D. Medical Oncologist at Duke University specializing in caring for patients with genitourinary cancers, including kidney, bladder, prostate, and testicular cancers, Discusses PEDIGREE Trial & The Role It Plays In Kidney Cancer. At the Seventeenth International Kidney Cancer Symposium on Nov 2, 2018.
by:kidneycancer | 117 views

About kidneycancer
Description: The Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest organization of its kind, with members in more than 100 countries. We fund, promote, and collaborate with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA), and other institutions on research projects. We educate families and physicians, and serve as an advocate on behalf of patients at the state and federal levels in the United States and globally.

Company: KCA was founded in 1990 by a small group of patients, including Eugene P. Schonfeld, Ph.D., and medical doctors in Chicago, Illinois. It is a nonprofit charity incorporated in the State of Illinois. I
Links
Channel Url:

Website:


Social Links: